logo

Editas Medicine Inc (EDIT) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Editas Medicine Inc’s current trading price is -54.16% away from its 52-week high, while its distance from the 52-week low is 3.31%. The stock’s price range during this period has varied between $5.28 and $11.91. The company, active in the Healthcare sector, saw a trading volume of around 1.64 million for the day, considerably lower average daily volume of 1.92 million observed over the last three months.

Editas Medicine Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $11.91 on 06/14/23, and the lowest price during the same period was recorded at $5.28 on 04/19/24.

How Financial Performance Impacts Market Capitalization

Editas Medicine Inc (EDIT) has experienced a quarterly decline of -34.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 448.98M and boasts a workforce of 265 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.47, with a change in price of -5.28. Similarly, Editas Medicine Inc recorded 1,907,908 in trading volume during the last 100 days, posting a change of -49.16%.

How EDIT’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for EDIT stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.07.

EDIT Stock Stochastic Average

As of today, the raw stochastic average of Editas Medicine Inc over the past 50 days is 2.78%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 7.61%. Additionally, the Stochastic %K and %D values for the company were 9.83% and 6.95%, respectively, over the past 20 days.

EDIT Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -46.10%.However, over the last six months, we can see a stronger performance of -13.20%. Over the last 30 days, the price of EDIT has leaped by -26.91%. And in the last five days, it has fallen by -6.67%.